01 14Cymbalta
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 239
2018 Revenue in Millions : 222
Growth (%) : 8
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 768
2019 Revenue in Millions : 725
Growth (%) : 6
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 251
2019 Revenue in Millions : 244
Growth (%) : 3
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 582
2020 Revenue in Millions : 768
Growth (%) : -24